Skip to main content
. 2019 Oct 11;7(1):e000795. doi: 10.1136/bmjdrc-2019-000795

Table 2.

Descriptive characteristics of patients with DFCs

Year 2007 2008 2009 2010 2011 2012 2013 2014 P for trend
Age (mean, SD) 65.33±12.84 65.84±13.05 65.83±13.19 65.92±13.34 66.27±13.42 66.33±13.47 66.06±13.58 66.30±13.63
Age≥60 years 15 305 (66.4) 17 483 (67.1) 18 352 (67.1) 19 356 (67.4) 20 431 (68.6) 20 762 (69.2) 20 713 (68.3) 21 276 (69.1) 0.003
Male gender (N, %) 12 511 (54.2) 14 387 (55.3) 15 271 (55.8) 16 055 (55.9) 16 616 (55.8) 16 991 (56.6) 17 320 (57.1) 17 584 (57.1) <0.001
Comorbidities (N, %)
 Hypertension 15 873 (68.8) 18 232 (70.0) 19 494 (71.2) 20 409 (71.0) 21 673 (72.8) 21 874 (72.9) 22 076 (72.8) 22 476 (73.0) 0.001
 Dyslipidemia 7960 (34.5) 9025 (34.7) 9781 (35.7) 10 570 (36.8) 11 371 (38.2) 11 593 (38.6) 12 419 (40.9) 13 067 (42.5) <0.001
 Diabetic nephropathy 3286 (14.2) 3812 (14.6) 4118 (15.1) 4667 (16.2) 4963 (16.7) 5187 (17.3) 5157 (17.0) 5258 (17.1) 0.001
 End-stage renal disease 1128 (4.9) 1435 (5.5) 1735 (6.3) 2103 (7.3) 2376 (8.0) 2421 (8.1) 2375 (7.8) 2382 (7.7) 0.008
 Diabetic retinopathy 452 (2.0) 520 (2.0) 502 (1.8) 540 (1.9) 507 (1.7) 497 (1.7) 403 (1.3) 377 (1.2) 0.001
 Diabetic neuropathy 1005 (4.4) 991 (3.8) 1035 (3.8) 1064 (3.7) 1045 (3.5) 1045 (3.5) 949 (3.1) 960 (3.1) <0.001
 Coronary heart disease 1309 (5.7) 1492 (5.7) 1510 (5.5) 1551 (5.4) 1739 (5.8) 1669 (5.6) 1784 (5.9) 1728 (5.6) 0.667
 Heart failure 740 (3.2) 824 (3.2) 920 (3.4) 1034 (3.6) 1065 (3.6) 1075 (3.6) 969 (3.2) 924 (3.0) 0.763
 Ischemic stroke 397 (1.7) 493 (1.9) 457 (1.7) 490 (1.7) 495 (1.7) 462 (1.5) 450 (1.5) 417 (1.4) 0.003
 Hemorrhagic stroke 21 (0.1) 36 (0.1) 35 (0.1) 44 (0.2) 31 (0.1) 49 (0.2) 29 (0.1) 31 (0.1) 0.740
 MACEs* 2467 (10.7) 2845 (10.9) 2922 (10.7) 3119 (10.9) 3330 (11.2) 3255 (10.9) 3232 (10.7) 3100 (10.1) 0.250

*MACEs: including coronary heart disease, heart failure, ischemic stroke and hemorrhagic stroke.

DFC, diabetic foot complication; MACE, major adverse cardiac event; N, number of patients.